THER (Theralink Technologies) Cyclically Adjusted PB Ratio: (As of Sep. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Theralink Technologies Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Theralink Technologies  (OTCPK:THER) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Theralink Technologies Cyclically Adjusted PB Ratio Related Terms


Theralink Technologies Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Theralink Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theralink Technologies Cyclically Adjusted PB Ratio Chart

Theralink Technologies Annual Data
Trend Feb14 Feb15 Dec16 Dec17 Dec18 Dec19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only

Theralink Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only

THER vs AXIM, ISCO, RMTG: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Theralink Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theralink Technologies Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theralink Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Theralink Technologies's Cyclically Adjusted PB Ratio falls into.



Theralink Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Theralink Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Theralink Technologies's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.009/306.7460*306.7460
=-0.009

Current CPI (Dec. 2023) = 306.7460.

Theralink Technologies Quarterly Data

Book Value per Share CPI Adj_Book
201208 1,597.364 230.379 2,126.865
201211 1,056.790 230.221 1,408.065
201302 102.849 232.166 135.888
201305 -32.708 232.945 -43.070
201308 -247.334 233.877 -324.396
201311 -398.299 233.069 -524.208
201402 -1,037.159 234.781 -1,355.069
201405 -1,185.537 237.900 -1,528.620
201408 -1,183.905 237.852 -1,526.824
201502 -1,734.113 234.722 -2,266.222
201505 -6.929 237.805 -8.938
201606 -4.392 241.018 -5.590
201609 -4.525 241.428 -5.749
201612 -10.197 241.432 -12.956
201703 10.723 243.801 13.491
201706 11.482 244.955 14.378
201709 -18.255 246.819 -22.687
201803 -17.812 249.554 -21.894
201806 -31.685 251.989 -38.570
201809 -30.418 252.439 -36.962
201812 -22.857 251.233 -27.908
201903 -29.651 254.202 -35.780
201906 -30.464 256.143 -36.482
201909 -28.550 256.759 -34.108
201912 -19.082 256.974 -22.778
202006 0.746 257.797 0.888
202009 0.000 260.280 0.000
202012 0.000 260.474 0.000
202103 -0.001 264.877 -0.001
202106 -0.001 271.696 -0.001
202109 -0.001 274.310 -0.001
202112 -0.001 278.802 -0.001
202203 -0.001 287.504 -0.001
202206 -0.001 296.311 -0.001
202209 -0.001 296.808 -0.001
202212 -0.007 296.797 -0.007
202303 -0.009 301.836 -0.009
202306 -0.008 305.109 -0.008
202309 -0.006 307.789 -0.006
202312 -0.009 306.746 -0.009

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Theralink Technologies Business Description

Address 15000 West 6th Avenue, Suite 400, Golden, CO, USA, 80401
Theralink Technologies Inc is a proteomics-based, precision medicine and molecular profiling company that specializes in patented Reverse Phase Protein Array (RPPA) and protein biomarker assay services that target multiple areas of oncology. The company provides precision oncology data through its Theralink Reverse Phase Protein Array (RPPA) assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. The firm is currently generating revenue with its multiple biopharma contracts and by testing breast cancer patients with its patented Theralink assay.